I am a pharmaceutical researcher with a strong interest in developing innovative, application-based drug delivery systems that translate scientific research into practical healthcare solutions. My work focuses on designing novel formulations that improve therapeutic outcomes while maintaining accessibility and affordability. During my PhD, I focused on addressing dysmenorrhea, a condition experienced by nearly 90% of women yet often underrecognized in healthcare research. My research involved the development of both an oral prodrug and a transdermal therapeutic cream formulation, MEFme, designed to provide effective relief through improved drug delivery strategies. Beyond academic research, I am the founder of RENMA Innovations Private Limited, a startup dedicated to developing health-focused consumer innovations. One of our early developments includes a prototype detox candy designed to support smokers’ health by addressing toxin exposure associated with nicotine use. I am passionate about translating scientific knowledge into impactful products and solutions. My long-term mission is to contribute to research that advances accessible and affordable healthcare for all.